Sunesis Pharmaceuticals Soars: Stock Adds 8% In Session - Tale Of The Tape

by Zacks, Benzinga Contributor
June 13, 2014 11:03 AM | 1 min read |
Sunesis Pharmaceuticals, Inc. SNSS was a big mover last session, as its shares rose roughly 8% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company, as the stock is now up over 16% in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sunesis Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. GILD, ANI Pharmaceuticals, Inc. ANIP and Illumina Inc. ILMN. All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
SUNESIS PHARMA SNSS: Free Stock Analysis Report
 
GILEAD SCIENCES GILD: Free Stock Analysis Report
 
ANI PHARMACEUT ANIP: Free Stock Analysis Report
 
ILLUMINA INC ILMN: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: MoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!